Assignee

NAPIGEN INC

US2 patents

Top patents by PatentIndex Score

US11920140B2Mar 5, 2024

Organelle genome modification using polynucleotide guided endonuclease

NAPIGEN INC3 citations64

US12173295B2Dec 24, 2024

Organelle genome modification using polynucleotide guided endonuclease

NAPIGEN INC0 citations52